eHealth Board Member Gets $1M+ Stock Package as Director Compensation
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
eHealth (EHTH) Director Prama Bhatt received an annual equity grant of 34,574 restricted stock units (RSUs) on June 17, 2025, as part of the company's non-employee director compensation program. The RSUs were granted at $0 cost and increased Bhatt's total beneficial ownership to 79,438 shares.
Key terms of the RSU grant:
- Vesting occurs in four equal quarterly installments starting June 17, 2025
- Full vesting acceleration triggers: - Day before next annual stockholder meeting - Upon Change in Control
- Vesting contingent on continued service as defined in the 2024 Equity Incentive Plan
This Form 4 filing was submitted by attorney-in-fact Sonwha Lee on June 20, 2025, within the required reporting timeline for insider transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Bhatt Prama
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 34,574 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 79,438 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What is the vesting schedule for EHTH Director Bhatt's RSU grant?
The RSUs vest in four equal quarterly installments starting from June 17, 2025. However, any unvested RSUs will fully vest either (1) the day before eHealth's next annual stockholder meeting or (2) if the company undergoes a Change in Control, subject to continued service as a director.
What was the purchase price of EHTH RSUs granted to Director Bhatt?
The RSUs were granted at $0 cost to Director Bhatt, as they were part of the annual equity compensation for non-employee directors under eHealth's 2024 Equity Incentive Plan.
When did EHTH Director Prama Bhatt file this Form 4?
The Form 4 was filed on June 20, 2025, within the required reporting window, as evidenced by the signature date on the filing. The reported transaction occurred on June 17, 2025.